EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS)

Richard S Judson iD, Doris Smith, Michael DeVito, John F Wambaugh iD, Barbara A Wetmore iD, Katie Paul Friedman, Grace Patlewicz iD, Russell S Thomas, Risa R Sayre iD, Jennifer H Olker iD, Sigmund Degitz, Stephanie Padilla iD und 3 weitere

Toxics · 05.04.2024 · 12 (4) · 271

DOI: 10.3390/toxics12040271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxics, online erschienen am 05.04.2024. Verfasst von Richard S Judson und 14 weiteren Autor:innen. Beteiligte Einrichtung: US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Per- and polyfluoroalkyl substances (PFAS) are widely used, and their fluorinated state contributes to unique uses and stability but also long half-lives in the environment and humans. PFAS have been shown to be toxic, leading to immunosuppression, cancer, and other adverse health outcomes. Only a small fraction of the PFAS in commerce have been evaluated for toxicity using in vivo tests, which leads to a need to prioritize which compounds to examine further. Here, we demonstrate a prioritization approach that combines human biomonitoring data (blood concentrations) with bioactivity data (concentrations at which bioactivity is observed in vitro) for 31 PFAS. The in vitro data are taken from a battery of cell-based assays, mostly run on human cells. The result is a Bioactive Concentration to Blood Concentration Ratio (BCBCR), similar to a margin of exposure (MoE). Chemicals with low BCBCR values could then be prioritized for further risk assessment. Using this method, two of the PFAS, PFOA (Perfluorooctanoic Acid) and PFOS (Perfluorooctane Sulfonic Acid), have BCBCR values < 1 for some populations. An additional 9 PFAS have BCBCR values < 100 for some populations. This study shows a promising approach to screening level risk assessments of compounds such as PFAS that are long-lived in humans and other species.

Schlagwörter

Stichwörter der Autor:innen

PFASbiomonitoringchemical prioritizationin vitromargin of exposure

Autor:innen und Institutionen

  • US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.

ORCID-Profile: Richard S Judson, John F Wambaugh, Barbara A Wetmore, Grace Patlewicz, Risa R Sayre, Jennifer H Olker, Stephanie Padilla, Joshua A Harrill

Zitieren

APA

Judson, R. S., Smith, D., DeVito, M., Wambaugh, J. F., Wetmore, B. A., Paul Friedman, K., Patlewicz, G., Thomas, R. S., Sayre, R. R., Olker, J. H., Degitz, S., Padilla, S., Harrill, J. A., Shafer, T., & Carstens, K. E. (2024). A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS). Toxics, 12(4), 271. https://doi.org/10.3390/toxics12040271

Vancouver

Judson RS, Smith D, DeVito M, Wambaugh JF, Wetmore BA, Paul Friedman K, et al. A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS). Toxics. 2024;12(4):271. doi:10.3390/toxics12040271

BibTeX
@article{Judson2024,
  author = {Judson, Richard S and Smith, Doris and DeVito, Michael and Wambaugh, John F and Wetmore, Barbara A and Paul Friedman, Katie and Patlewicz, Grace and Thomas, Russell S and Sayre, Risa R and Olker, Jennifer H and Degitz, Sigmund and Padilla, Stephanie and Harrill, Joshua A and Shafer, Timothy and Carstens, Kelly E},
  title = {A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS)},
  journal = {Toxics},
  year = {2024},
  volume = {12},
  number = {4},
  pages = {271},
  doi = {10.3390/toxics12040271}
}
Kostenlos starten →